CCND1 and cancer: It has been shown that ERK1/2 positively regulates both proliferation-related (e.g. c-Myc, Cyclin D1) and migration-related (e.g. matrix metalloproteinase-2; MMP2) proteins to drive cancer cell progression [32–34].